FDA Guidelines on Safety Reporting Requirements for IND BA and BE Discussion
In the FDA’s guidance document “Safety Reporting Requirements for INDs and BA/BE Studies,” the FDA outlines the importance of identifying and characterizing adverse events that arise during the course of clinical trials. Importantly, the FDA outlines the types of events that MUST be reported to the FDA in the form of IND Safety Reports. Describe […]
